Specialty Pharmacy

A toxin in bee venom may put an end to HIV in the future.

Top news of the day from across the health care landscape.

The FDA approved nusinersen (Spinraza) for the treatment of patients with spinal muscular atrophy.

The rule builds on the FDA’s ongoing effort to encourage complete postmarketing safety data on various biologic and device products.

Both combination product applicants and constituent part applicants are required to comply with postmarketing safety reporting rules.

Most quality indicators for diabetes care monitor risk factors to see if patients are reaching their target levels.

FDA proposal would add 6 bulk drug substances and remove 4 substances that can be used in compounding.

Revisions would add 6 bulk drug substances and remove 4 substances that can be used in compounding.

Top articles of the year on Specialty Pharmacy Times.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how specialty pharmacies can best demonstrate value as health care transitions to a value-based system.

Reduced reimbursements, Medicare Part D, and the Affordable Care Act have stimulated pharmacies to offer a broader palette of services.

Biosimilar erythropoiesis-stimulating agent epoetin was well-tolerated and efficacious in the treatment of geriatric patients with chemotherapy-induced anemia.

Smaller co-payments for prescription drugs leaves individuals less likely to visit the hospital.

Top oncology articles of 2016 on Specialty Pharmacy Times.

New cancer-spreading protein discovered in groundbreaking study.

Relapsed or refractory leukemia patients who received CC-486 had a 38% overall response rate.

Breast cancer patients with many social ties have significantly lower rates of death and recurrence.

Nivolumab plus ipilimumab deemed tolerable in non-small cell lung cancer patients, with notable improvements in safety.

Billions wasted each year from lack of adherence to prescription medications.

Combination drugs may cause adverse events in individuals coinfected with HIV and HCV.

Study findings may improve the prevention and treatment of rheumatoid arthritis.

Combination cancer drug shows the potential to help with fertility in the future.

Babies born with low levels of vitamin D face an increased risk of developing MS in the future.

Top articles of 2016 on Specialty Pharmacy Times.

Pharmaceutical manufacturers historicially reaped the benefits of operating independently in pricing and discounting drugs based on volume sold in the United States.

Anti-vascular endothelial growth factor agents are the criterion standard for diabetic macular edema.

Rinku A. Patel, PharmD, RPh, founder and CEO at KloudScipt, discusses effective integration of technology in the pharmacy setting.

Thioguanine and decitabine combination therapy show positive results in phase 1 trial.